Patents by Inventor Hengyu XU

Hengyu XU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220230712
    Abstract: The techniques described herein relate to methods and apparatus for determining a set of reactions to produce a target product. The method includes receiving the target product, executing a graph traversal thread, requesting, via the graph traversal thread, a first set of reactant predictions for the target product, executing a molecule expansion thread, determining, via the molecule expansion thread and a reactant prediction model, the first set of reactant predictions, and storing the first set of reactant predictions as at least part of the set of reactions.
    Type: Application
    Filed: January 20, 2022
    Publication date: July 21, 2022
    Applicant: Kebotix, Inc.
    Inventors: Dennis Sheberla, Christoph Kreisbeck, Kevin Ryan, Chandramouli Nyshadham, Hengyu Xu
  • Patent number: 10202447
    Abstract: The invention relates inter alia to a bivalent, bispecific construct comprising an anti-IL-6 antibody, or derivative thereof, and an anti-IL-23 antibody, or derivative thereof and its use in therapy. The invention also relates to useful anti-IL-6 antibodies and anti-IL-23 antibodies.
    Type: Grant
    Filed: October 19, 2015
    Date of Patent: February 12, 2019
    Assignee: MedImmune Limited
    Inventors: Kenneth Grabstein, William Brady, Gordon King, Natalie Winblade Nairn, Kurt David Shanebeck, Paul Heffner Slagle, Kenneth Christopher Thornton, Michael Peter Vanbrunt, Andrea Wang, Hengyu Xu
  • Publication number: 20160194391
    Abstract: The invention relates inter alia to a bivalent, bispecific construct comprising an anti-IL-6 antibody, or derivative thereof, and an anti-IL-23 antibody, or derivative thereof and its use in therapy. The invention also relates to useful anti-IL-6 and anti-IL-23 antibodies.
    Type: Application
    Filed: October 19, 2015
    Publication date: July 7, 2016
    Inventors: Kenneth Grabstein, William Brady, Gordon King, Natalie Winblade Nairn, Kurt David Shanebeck, Paul Heffner Slagle, Kenneth Christopher Thornton, Michael Peter Vanbrunt, Andrea Wang, Hengyu Xu
  • Publication number: 20140127209
    Abstract: The invention relates inter alia to a bivalent, bispecific construct comprising an anti-IL-6 antibody, or derivative thereof, and an anti-IL-23 antibody, or derivative thereof and its use in therapy. The invention also relates to useful anti-IL-6 antibodies and anti-IL-23 antibodies.
    Type: Application
    Filed: March 8, 2013
    Publication date: May 8, 2014
    Inventors: Kenneth GRABSTEIN, William BRADY, Gordon KING, Natalie Winblade NAIRN, Kurt David SHANEBECK, Paul Heffner SLAGLE, Kenneth Christopher THORNTON, Michael Peter VANBRUNT, Andrea WANG, Hengyu XU